HOME > About us > Corporate profile
HansBiomed Corporation
HansBiomed Corporation is the first Asian tissue bank approved by US FDA and we produce safe and high
quality allograft products and biological implants in accordance with guidelines and/or standards of US FDA,
EATB (European Association of Tissue Bank), and AATB (American Association of Tissue Bank). About 60
researchers and quality control personnel are working at HansBiomed Research & Development Center (HDI)
to ensure the safety and quality of and to improve these products. HDI has an intellectual property right
including human dermal matrix processing.
Our mission is to be the ideal partner for aesthetic and reconstructive solutions to help healthcare
professionals make a real and long-lasting difference to the well-being of patients, empowering them to lead
healthier and more satisfying lives.
Science and innovation
HansBiomed Corp. is dedicated to providing innovative, safe and effective health solutions with supportive
scientific evidences. We have been pursuing for development of innovating new products for aesthetic
surgery and human tissue engineering field since the establishment of the company. Thanks to allocation of
more than 20% corporate revenue to the research and development, we now become competitive with name
brand products worldwide.